Antigenesis Biologics

About Antigenesis Biologics

Antigenesis is a pioneering biotech company revolutionising veterinary medicine by bringing human-grade therapeutic innovations to companion animals. We develop first-in-class antibody therapeutics for critical unmet needs in veterinary care, beginning with oncology and expanding to other serious conditions that limit the quality and length of our pets' lives. At our core is a simple belief: animals deserve access to the same cutting-edge care as humans—and we're making that a reality. By leveraging our expertise in human therapeutics alongside advanced AI/ML technology, we create targeted, safe, and effective treatments that were previously unavailable in veterinary medicine. Our approach significantly reduces development risks and costs whilst accelerating the delivery of life-changing treatments to market. Antigenesis is committed to transforming how life-limiting conditions are treated in companion animals through responsible innovation and rigorous science. We're building a future where veterinary medicine no longer lags behind human healthcare, where breakthrough treatments extend and improve the lives of the animals who bring so much joy to our families. Join us as we shape the future of veterinary healthcare and make a meaningful difference in the lives of our animal family members.

View contact profiles from Antigenesis Biologics